DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

AKI India Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 6 hrs ago·14 Oct 2026, 12:39 pm

AKI India

Aki India Limited has informed the stock exchanges that it has obtained a certificate under the SEBI (Depositories and Participants) Regulations, 2018. This certificate is a mandatory compliance requirement for entities that act as Depository Participants (DPs) and is issued by depositories like NSDL and CDSL.

For investors, this news is a positive signal. It confirms that the company is fully compliant with regulatory standards and has the necessary infrastructure to handle dematerialization of securities. This status is crucial for maintaining trust and ensuring smooth operations in the securities market.

Investors should note that this is a routine regulatory update rather than a major corporate development. The stock price may react based on market sentiment, but the certificate itself does not alter the company's fundamental business performance or financial outlook.